These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8531379)

  • 1. [The molecular mechanism of costimulatory signal for T cell activation].
    Uede T
    Nihon Rinsho; 1995 Oct; 53(10):2597-603. PubMed ID: 8531379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.
    Damle NK; Klussman K; Linsley PS; Aruffo A
    J Immunol; 1992 Apr; 148(7):1985-92. PubMed ID: 1372018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
    Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
    Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.
    Linsley PS; Bradshaw J; Urnes M; Grosmaire L; Ledbetter JA
    J Immunol; 1993 Apr; 150(8 Pt 1):3161-9. PubMed ID: 7682233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation.
    Muraille E; De Smedt T; Thielemans K; Urbain J; Moser M; Leo O
    Cell Immunol; 1995 May; 162(2):315-20. PubMed ID: 7538050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
    Dubey C; Croft M; Swain SL
    J Immunol; 1995 Jul; 155(1):45-57. PubMed ID: 7541426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CD28/B7 costimulating signal and its clinical significance].
    Qu MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):265-7. PubMed ID: 12513801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86].
    Nakajima A; Azuma M
    Nihon Rinsho; 1997 Jun; 55(6):1419-24. PubMed ID: 9200926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
    Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRC OX-2 defines a novel T cell costimulatory pathway.
    Borriello F; Lederer J; Scott S; Sharpe AH
    J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
    Young JW; Koulova L; Soergel SA; Clark EA; Steinman RM; Dupont B
    J Clin Invest; 1992 Jul; 90(1):229-37. PubMed ID: 1378854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28/B7 system of T cell costimulation.
    Lenschow DJ; Walunas TL; Bluestone JA
    Annu Rev Immunol; 1996; 14():233-58. PubMed ID: 8717514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions.
    Goldstein JS; Chen T; Brunswick M; Mostowsky H; Kozlowski S
    J Immunol; 1998 Apr; 160(7):3180-7. PubMed ID: 9531273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein.
    Blanco B; Holliger P; Alvarez-Vallina L
    Cancer Gene Ther; 2002 Mar; 9(3):275-81. PubMed ID: 11896444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
    Ding L; Shevach EM
    Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-1-HSA (CD80-CD24), a recombinant hybrid costimulatory molecule retains ligand binding and costimulatory functions.
    Wang YC; Sashidharamurthy R; Nagarajan S; Selvaraj P
    Immunol Lett; 2006 Jun; 105(2):185-92. PubMed ID: 16621031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation.
    Sansom DM; Wilson A; Boshell M; Lewis J; Hall ND
    Immunology; 1993 Oct; 80(2):242-7. PubMed ID: 7505258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation and maintenance of CD4+ T-cell proliferation after activation with suboptimal doses of PHA.
    Vasilevko V; Ghochikyan A; Holterman MJ; Agadjanyan MG
    DNA Cell Biol; 2002 Mar; 21(3):137-49. PubMed ID: 12015893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.